Showing results (171-180 of 221) with videos related to
Sort By:
Pageof 23
Headache|March 14, 2025
Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME (US) studyDawn C Buse, E Jolanda Muenzel, Anthony J Zagar, et al.Cephalalgia : an International Journal of Headache|August 31, 2023
Harassment in the headache field: a global web-based cross-sectional surveyIrene de Boer, Anna Ambrosini, Rashmi B Halker Singh, et al.Headache|June 19, 2015
Clinical Pain Catastrophizing in Women With Migraine and ObesityDale S Bond, Dawn C Buse, Richard B Lipton, et al.Cephalalgia : an International Journal of Headache|September 8, 2022
Perceived barriers to career progression in the headache field: A global web-based cross-sectional surveyIrene de Boer, Anna Ambrosini, Rashmi B Halker Singh, et al.Headache|July 23, 2020
Ten Eleven Things Not to Say to Healthcare Professionals During the Coronavirus Disease 2019 PandemicJennifer Robblee, Dawn C Buse, Rashmi B Halker Singh, et al.ACS Pharmacology & Translational Science|October 19, 2020
Anti-Opioid Antibodies in Individuals Using Chronic Opioid Therapy for Lower Back PainJillian L Kyzer, Mason McGuire, Hyeri Park, et al.Neurology and Therapy|December 17, 2025
Real-World Experience with Anti-CGRP Pathway Monoclonal Antibodies in a Large United States Healthcare Plan: Results of the Migraine Signature StudyDawn C Buse, Richard B Lipton, Robert Urman, et al.Headache|February 19, 2025
Behavioral interventions for migraine prevention: A systematic review and meta-analysisJonathan R Treadwell, Amy Y Tsou, Benjamin Rouse, et al.The Journal of Headache and Pain|February 8, 2022
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF studyPeter McAllister, Paul K Winner, Jessica Ailani, et al.The Journal of Headache and Pain|August 19, 2024
Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) studyMichel Lanteri-Minet, Elizabeth Leroux, Zaza Katsarava, et al.Pageof 23